India Mice Model Market (2025-2030)
The India Mice Model Market was valued at $23 Million in 2025 and projected to reach to $37 Million by 2030, representing a compound annual growth rate of 10.0%. India's mice model market is poised for sustained growth as the country strengthens its position as a global pharmaceutical and biotechnology hub.
India Mice Model Market Trends and Insights
- India's pharmaceutical and biotechnology sectors are increasingly adopting mice models for preclinical research, drug development, and toxicology studies, driven by rising R&D investments and regulatory compliance requirements.
- The market in India benefits from cost-effective research infrastructure, a growing pool of skilled researchers, and expanding collaborations between academic institutions and pharmaceutical companies. India's position as a global research hub is strengthening demand for mice models across contract research organizations (CROs) and academic centers.
- Between 2025 and 2030, India is expected to witness accelerated adoption of genetically modified mice and specialized disease models, particularly in oncology, immunology, and metabolic disorder research.
- Government initiatives supporting life sciences research and increasing foreign direct investment in India's biotech sector are key catalysts propelling the mice model market forward during this forecast period..
Key Market Statistics
- CAGR (2025-2030) 10.0% CAGR
- Market Size, 2025 ~USD 23 Million
- Forecast, 2030 ~USD 37 Million
- Country India
India Mice Model Market Overview
Market Valuation Growth :
India's mice model market is valued at $23.0 million in 2025 and is projected to reach $37.0 million by 2030, demonstrating strong market expansion driven by increased pharmaceutical R&D activities across the country.
Pharma & Biotech Adoption :
Indian pharmaceutical and biotechnology companies are increasingly integrating mice models into preclinical research pipelines, accelerated by rising investments in drug development and stringent regulatory compliance requirements.
Regulatory Compliance Driver :
Growing adherence to international regulatory standards and guidelines for drug safety testing is propelling demand for standardized mice models in India's research institutions and contract research organizations.
R&D Investment Surge :
Significant increases in government and private sector R&D funding, coupled with expansion of research facilities, are creating robust demand for mice models in toxicology studies and disease research across India.
India Mice Model Market Dynamics
- The 10% CAGR through 2030 reflects increasing adoption of preclinical research models among Indian pharmaceutical companies, CROs, and academic institutions.
- Rising R&D investments, coupled with regulatory pressures to conduct comprehensive safety testing, are driving market expansion.
- India's cost-competitive research environment and growing emphasis on drug discovery innovation are attracting both domestic and international pharmaceutical players to establish research operations in the country.
- The market is expected to benefit from expanding collaborations between Indian biotech firms and global pharmaceutical companies seeking cost-effective preclinical research solutions..
Related Ecosystem
Biotechnology
- Reagents
- Polymerase Chain Reaction (PCR)
- Stem Cells
- Assay Kits
- Flow Cytometers
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
Key Takeaways
- India's mice model market is valued at $23.0 million in 2025 and is forecast to reach $37.0 million by 2030, growing at a 10.0% CAGR.
- India's cost-effective research infrastructure and skilled workforce position the country as a preferred destination for preclinical research outsourcing.
- Rising pharmaceutical R&D investments and regulatory compliance requirements are driving increased adoption of mice models across India's biotech and CRO sectors.
- Genetically modified mice and specialized disease models are expected to gain significant traction in India between 2025 and 2030, particularly in oncology and immunology research.
Mice Model Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | SERVICES (Model Type & Service) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 10% from 2025 to 2030 |
| Largest Segment | MODEL TYPE (Model Type & Service) |
| Market Size Base Year (Billions) | ~USD 1.7 (2025) |
| Revenue Forecast (Billions) | ~USD 2.74 (2030) |
| Segments Covered | Model Type & Service, Type, Technology, Application, Therapeutic Area |
India Mice Model Market Report Segmentation
5 segment dimensions are covered across the global market.
By Model Type & Service
- Model Type
- Services
By Type
- Breeding Services
- Cryopreservation Services
- Genetically Engineered Mice
- Hybrid/Congenic Mice
- Inbred Mice
- Other Services
- Outbred Mice
- Quarantine Services
- Rederivation Services
By Technology
- Crispr/Cas9
- Embryonic Stem Cell Injections
- Microinjections
- Nuclear Transfer Technique
- Other Technologies
By Application
- Drug Discovery & Development
- Personalized Medicine
- Research Applications
By Therapeutic Area
- Cardiovascular Diseases
- Immunology
- Metabolic Diseases
- Neurology
- Oncology
- Other Therapeutic Areas
Target Audience
- Indian Pharmaceutical Companies : Need market intelligence to benchmark R&D investments, understand competitive positioning, and identify opportunities to expand preclinical research capabilities within India's growing market.
- Contract Research Organizations (CROs) : Require India-specific market data to assess demand for mice model services, plan capacity expansion, and develop service offerings aligned with local pharmaceutical and biotech client needs.
- Biotech Startups & Research Institutions : Seek market insights to validate business models, secure funding, and understand the regulatory environment and growth drivers specific to India's preclinical research landscape.
- Global Pharmaceutical Companies : Need India market analysis to evaluate outsourcing opportunities, identify local research partners, and assess the cost-benefit of establishing or expanding preclinical research operations in India.
- Laboratory Animal Suppliers & Vendors : Require market forecasts and demand trends specific to India to optimize supply chain strategies, plan inventory, and identify growth opportunities in the expanding Indian research animal market.
Key Companies in the India Mice Model Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| HORIZON DISCOVERY GROUP PLC | United Kingdom | Private Company | Screening,Research Reagents,Diagnostics, |
| LABORATORY CORPORATION OF AMERICA HOLDINGS | United States | Public Company | Routine and wellness diagnostics (chemistry, hematology, urinalysis, wellness programs),Specialty and esoteric testing (gene-based, oncology, infectious disease, women’s health, pharmacogenetics),Biopharma Laboratory Services (clinical trial, central lab, medical device and diagnostic R&D), |
| CHARLES RIVER LABORATORIES | United States | Public Company | Discovery and Safety Assessment,Research Models and Services,Manufacturing Solutions, |
| THE JACKSON LABORATORY | United States | Foundation/Charitable Institution | Mouse breeding and colony management services,Cryopreservation, recovery, and genetic resource management,Phenotyping, efficacy testing, and study-ready induced models, |
| INOTIV | United States | Public Company | Research Models and Services (RMS),Discovery and Safety Assessment (DSA) Services,BASi Scientific Instruments and Software, |
| JSR CORPORATION | Japan | Private Company | Digital Solutions (lithography, photoresists, packaging, CMP, display materials),Plastics (synthetic resins: ABS, AES, AS, ASA),Life Sciences (diagnostic reagents, bioprocess materials, drug discovery support), |
| BIOCYTOGEN | China | Public Company | Gene-Editing Services,Pharmacological Efficacy & Toxicology Services,Model Animals (Breeding & Sales), |
| SHANGHAI MODEL ORGANISMS CENTER, INC. | China | Public Company | Standard and disease mouse models (including toolbox and disease-specific strains),Customized genetically engineered models (KO, KI, humanized, transgenic),Preclinical services (non-GLP tox, PK, pharmacology/PD, phenotype analysis), |
| TRANS GENIC INC. | Japan | Public Company | Drug Discovery Support (non-clinical, bioequivalence, safety tests),Transgenic Models & Reagents (GM mice, antibodies, proteins, cells),Glycan Synthesis & Sugar Chain Analysis, |
| HARBOUR BIOMED | China | Public Company | Harbour Mice platform licensing and collaborations,Immunology clinical assets (e.g., batoclimab, HBM7020, HBM9378),Oncology clinical assets (e.g., porustobart, solid tumor portfolio), |
| GENOWAY | France | Public Company | Custom KO/KI mouse models,Custom KO/KI rat models,Humanized and immunodeficient rodent models (catalog and custom), |
| GEMPHARMATECH | China | Public Company | Standard GEMM catalog (knockout, conditional, knock-in, point-mutation, transgenic),Custom model generation and tool mice,Preclinical testing services, |
| VIVO BIO TECH LTD. | India | Public Company | In vivo and in vitro toxicity, PK/TK, and pharmacology services,SPF lab animals, rodent breeding, custom models, and lab diets,Genotoxicity screening and analytical services, |
HORIZON DISCOVERY GROUP PLC
Horizon Discovery Group PLC is a United Kingdom-based private company founded in 2005 with 428 employees. The company operates in the life sciences sector, providing specialized research and development services.
LABORATORY CORPORATION OF AMERICA HOLDINGS
Laboratory Corporation of America Holdings is a major United States public company founded in 1995 with 66,385 employees. It is a leading provider of clinical laboratory services and drug development support.
CHARLES RIVER LABORATORIES
Charles River Laboratories is a United States public company founded in 1947 with 19,000 employees. The company provides preclinical and clinical laboratory services, research models, and safety assessment services.
THE JACKSON LABORATORY
The Jackson Laboratory is a United States foundation and charitable institution founded in 1929 with 2,100 employees. It is a premier research institution specializing in mammalian genetics and genomics.
INOTIV
Inotiv is a United States public company founded in 1974 with 1,996 employees. The company provides research models, services, and products for the pharmaceutical and biotechnology industries.
JSR CORPORATION
JSR Corporation is a Japan-based private company founded in 1948 with 7,997 employees. The company operates in advanced materials and life sciences sectors.
BIOCYTOGEN
Biocytogen is a China-based public company founded in 2008 with 1,443 employees. The company specializes in the development of genetically engineered animal models for research and drug development.
SHANGHAI MODEL ORGANISMS CENTER, INC.
Shanghai Model Organisms Center, Inc. is a China-based public company founded in 2000 with 848 employees. The company provides model organism services and products for biomedical research.
TRANS GENIC INC.
Trans Genic Inc. is a Japan-based public company founded in 1998 with 227 employees. The company develops and provides transgenic animal models for research applications.
HARBOUR BIOMED
Harbour Biomed is a China-based public company founded in 2016 with 272 employees. The company focuses on antibody and immunotherapy research and development.
GENOWAY
Genoway is a France-based public company founded in 1999 with 157 employees. The company specializes in the generation of genetically modified animal models for research.
GEMPHARMATECH
GemPharmatech is a China-based public company founded in 2017 with 1,590 employees. The company provides laboratory animal models and related research services.
VIVO BIO TECH LTD.
Vivo Bio Tech Ltd. is an India-based public company founded in 1987 with 174 employees. The company provides contract research services and laboratory animal models for pharmaceutical and biotechnology research.
Reasons to Buy this Report
- India-Specific Market Sizing : Access precise valuation data for India's mice model market with verified estimates for 2025 ($23M) and 2030 ($37M), enabling accurate budget allocation and investment planning specific to the Indian market.
- Regulatory & Compliance Insights : Understand India-specific regulatory drivers and compliance requirements influencing mice model adoption, helping stakeholders navigate local guidelines and optimize research operations accordingly.
- Competitive Landscape Analysis : Identify key Indian pharmaceutical companies, CROs, and research institutions driving market growth, enabling strategic partnerships and competitive positioning within India's evolving research ecosystem.
- Growth Opportunity Assessment : Leverage India's 10% CAGR forecast to identify high-potential segments within preclinical research, drug development, and toxicology testing for market entry or expansion strategies.
- Investment Decision Support : Make informed investment and expansion decisions based on India-specific market trends, R&D investment patterns, and the country's emerging role as a cost-effective global research destination.
Frequently asked questions
What is the current size of India's mice model market in 2025?
India's mice model market is valued at $23.0 million in 2025, reflecting strong demand from pharmaceutical, biotechnology, and contract research organizations.
What is the projected market size for India's mice model market by 2030?
India's mice model market is projected to reach $37.0 million by 2030, representing a 10.0% compound annual growth rate over the forecast period.
What factors are driving growth in India's mice model market?
Key growth drivers in India include rising R&D investments, cost-effective research infrastructure, regulatory compliance requirements, and increasing adoption of preclinical research outsourcing by global pharmaceutical companies.
Which research areas are experiencing the highest demand for mice models in India?
India is witnessing strong demand for mice models in oncology, immunology, metabolic disorder research, and drug development, driven by expanding pharmaceutical and biotech sectors.
How does India's mice model market compare to other Asia Pacific countries?
India is emerging as a key hub for mice model research in Asia Pacific, leveraging cost advantages, skilled researchers, and growing biotech infrastructure to attract global research partnerships and investments.
RESEARCH METHODOLOGY
This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global mice model market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.
Secondary Research
Secondary research was used primarily to identify & collect information for the extensive, technical, market-oriented, and commercial study. The secondary sources used for this study include the International Mouse Phenotyping Consortium (IMPC), Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC), European Molecular Biology Laboratory−European Bioinformatics Institute (EMBL-EBI), Swiss Laboratory Animal Science Association (SGV), Medical Research Council (MRC), Asian Mouse Mutagenesis Resource Association (AMMRA), Department of Biotechnology (DBT) (India), World Health Organization (WHO), United States Food and Drug Administration (US FDA), Annual Reports, SEC Filings, Investor Presentations, Research Journals, Press Releases, and financial statements. These sources also obtained key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative & quantitative information and assess the prospects of the market. Various primary sources from both the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate & validate the total size of the mice model market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Data Triangulation
The total market was split into several segments and subsegments after arriving at the overall market size from the estimation process. Where applicable, data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
An animal model is a valuable resource in biomedical research, chosen for its ability to replicate certain aspects of biological processes or diseases observed in humans. A mouse model is a genetically engineered or naturally occurring mouse strain used in biomedical research to mimic human diseases or conditions. These models are valuable for their biological similarity to humans, ability to be genetically manipulated, and cost-effectiveness, enabling researchers to study disease mechanisms and test novel drug therapies efficiently. Mice share over 95% of human DNA and are biologically similar to humans, thereby being susceptible to similar diseases due to the genetic build-up.
Stakeholders
- Manufacturers & Distributors of Mice Models
- CROs & CDMOs
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Market Research & Consulting Firms
- Researchers & Scientists
- Regulatory Authorities & Institutes
Report Objectives
- To define, describe, and forecast the global mice model market based on model type & service, technology, therapeutic area, application, product end user, service end user, and region
- To provide detailed information regarding the leading factors driving the growth of the market (such as drivers, restraints, challenges, and opportunities)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall mice models market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six regions: North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
- To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- Track & analyze competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and R&D activities in the mice models market.
- To analyze and provide funding & investment activities, brand/product comparative analysis, and vendor valuation & financial metrics of the mice model market.
Get the Full Mice Model Market Report
Full forecast, segment splits, and company analysis for all Mice Model Market.
- US Mice Model Market
- Canada Mice Model Market
- Germany Mice Model Market
- UK Mice Model Market
- France Mice Model Market
- Italy Mice Model Market
- Spain Mice Model Market
- China Mice Model Market
- Japan Mice Model Market
- Australia Mice Model Market
- South Korea Mice Model Market
- Brazil Mice Model Market
- Mexico Mice Model Market
- United Arab Emirates Mice Model Market
- Rest Of Europe Mice Model Market
- Rest Of The Asia Pacific Mice Model Market
- Rest Of Asia Pacific Mice Model Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report